{ "items": [ "\n\n
Mogire RM. et al, (2021), BMC medicine, 19
\n \n \n \n\n \n
\n \n \nMwangi SJ. et al, (2021), Wellcome Open Research, 5, 197 - 197
\n \n \n \n\n \n
\n \n \nMuriuki JM. et al, (2021), Nature Medicine, 27, 653 - 658
\n \n \n \n\n \n
\n \n \nSutton HJ. et al, (2021), Cell reports, 34
\n \n \n \n\n \n
\n \n \nMwangi SJ. et al, (2020), Wellcome Open Research, 5, 197 - 197
\n \n \n \n\n \n
\n \n \nAye R. et al, (2020), European Journal of Immunology, 50, 1187 - 1194
\n \n \n \n\n \n
\n \n \nSutton H. et al, (2020)
\n \n \n \n\n \n
\n \n \nMuriuki JM. et al, (2020), BMC medicine, 18
\n \n \n \n\n \n
\n \n \nMuriuki JM. et al, (2020), BMC Medicine, 18
\n \n \n \n\n \n
\n \n \nKhaemba EN. et al, (2020), Wellcome Open Research, 5, 36 - 36
\n \n \n \n\n \n
\n \n \nP\u00e9rez-Mazliah D. et al, (2020), Immunological reviews, 293, 57 - 69
\n \n \n \n\n \n
\n \n \nPejoski D. et al, (2020), NPJ vaccines, 5
\n \n \n \n\n \n
\n \n \nJahnmatz P. et al, (2020), Frontiers in immunology, 11
\n \n \n \n\n \n
\n \n \nPejoski D. et al, (2020), NPJ vaccines, 5
\n \n \n \n\n \n
\n \n \nOsii RS. et al, (2020), Frontiers in immunology, 11
\n \n \n \n\n \n
\n \n \nMuriuki JM. et al, (2019), Science advances, 5
\n \n \n \n\n \n
\n \n \nMandal RK. et al, (2019), The Journal of infectious diseases, 220, 687 - 698
\n \n \n \n\n \n
\n \n \nMuriuki JM. et al, (2019), Clinical Infectious Diseases, 68, 1807 - 1814
\n \n \n \n\n \n
\n \n \nBediako Y. et al, (2019), BMC medicine, 17
\n \n \n \n\n \n
\n \n \nNdungu FM. et al, (2019), Wellcome Open Research, 4, 42 - 42
\n \n \n \n\n \n
\n \n \n